IDEAYA Biosciences Inc logo

IDEAYA Biosciences Inc

IDYA
Healthcare|Biotechnology|USA
$36.99
-0.29 (-0.78%)
Tangible Book
$10.67

About

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Stock Price

+62.2%(1Y)

Pipeline Summary

11 total trials
8
Phase 1
5
Phase 2
2
Phase 3
0
Phase 4
Recruiting: 6Active: 5

Active Trials (11)

Neoadjuvant Darovasertib in Primary Uveal Melanoma
NCT07015190Uveal Melanoma
Phase 3Recruiting
Enrollment: 520 participants
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
NCT03947385Metastatic Uveal Melanoma
Phase 1Phase 2Recruiting
Enrollment: 336 participants
IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma
NCT05987332Metastatic Uveal Melanoma
Phase 2Phase 3Active
Enrollment: 420 participants
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
NCT07540572ER+, HER 2- Breast Cancer
Phase 1Recruiting
Enrollment: 160 participants
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
NCT07277413NSCLC Adenocarcinoma
Phase 1Recruiting
Enrollment: 260 participants
View all 11 active trials →

BioScore

5.6/10
Watchlist

Ownership

Recent Insider Trades

Ruiz Briseno AndresSELL
2026-07-079,550 shares @ $40.01
Stein JeffreyBUY
2026-03-0250,000 shares @ $32.96
WHITE MICHAEL ANTHONYSELL
2024-05-2928,500 shares @ $36.24
Hata Yujiro SSELL
2024-05-16175,000 shares @ $42.27
Hata Yujiro SSELL
2024-02-0999,372 shares @ $45.24

Recent News

2026-07-07 16:38:17
2026-07-07 13:03:31
2026-06-26 11:00:02
2026-06-17 11:00:05
2026-06-17 10:50:44
Data last updated: Jul 12, 2026, 07:38 PM